Effect of Statins on COPD
Authors:
- 1 December 2017
- Vol. 152 (6) , 1159-1168
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease managementExpert Opinion on Drug Delivery, 2011
- Simvastatin Inhibits Airway Hyperreactivity: Implications for the Mevalonate Pathway and BeyondAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertensionClinical Science, 2009
- Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEuropean Respiratory Journal, 2008
- Usefulness of C-Reactive Protein and Interleukin-6 as Predictors of Outcomes in Patients With Chronic Obstructive Pulmonary Disease Receiving PravastatinThe American Journal of Cardiology, 2008
- Mortality in COPD: role of comorbiditiesEuropean Respiratory Journal, 2006
- Reduction of Morbidity and Mortality by Statins, Angiotensin-Converting Enzyme Inhibitors, and Angiotensin Receptor Blockers in Patients With Chronic Obstructive Pulmonary DiseaseJACC, 2006
- Simvastatin Inhibits Cigarette Smoking–induced Emphysema and Pulmonary Hypertension in Rat LungsAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Systemic inflammation in chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population studyBMJ, 1996